Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VEDOLIZUMAB Cause Drug effect less than expected? 461 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 461 reports of Drug effect less than expected have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.6% of all adverse event reports for VEDOLIZUMAB.

461
Reports of Drug effect less than expected with VEDOLIZUMAB
0.6%
of all VEDOLIZUMAB reports
1
Deaths
103
Hospitalizations

How Dangerous Is Drug effect less than expected From VEDOLIZUMAB?

Of the 461 reports, 1 (0.2%) resulted in death, 103 (22.3%) required hospitalization, and 1 (0.2%) were considered life-threatening.

Is Drug effect less than expected Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 461 reports have been filed with the FAERS database.

What Other Side Effects Does VEDOLIZUMAB Cause?

Off label use (21,017) Colitis ulcerative (13,455) Crohn's disease (9,759) Drug ineffective (8,424) Diarrhoea (7,493) Abdominal pain (6,401) Fatigue (5,477) Haematochezia (5,215) Frequent bowel movements (4,527) Arthralgia (4,028)

What Other Drugs Cause Drug effect less than expected?

DUPILUMAB (1,204) DICLOFENAC (647) PRABOTULINUMTOXINA-XVFS (354) OFATUMUMAB (319) EPTINEZUMAB-JJMR (298) IBUPROFEN (218) TOFACITINIB (210) SECUKINUMAB (190) ACETAMINOPHEN\IBUPROFEN (163) ACETAMINOPHEN\ASPIRIN\CAFFEINE (134)

Which VEDOLIZUMAB Alternatives Have Lower Drug effect less than expected Risk?

VEDOLIZUMAB vs VELAGLUCERASE ALFA VEDOLIZUMAB vs VELCADE VEDOLIZUMAB vs VELETRI VEDOLIZUMAB vs VELIPARIB VEDOLIZUMAB vs VEMURAFENIB

Related Pages

VEDOLIZUMAB Full Profile All Drug effect less than expected Reports All Drugs Causing Drug effect less than expected VEDOLIZUMAB Demographics